Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China
Clinical trial NCT05886244 · COMPLETED
Trial details
- NCT number
- NCT05886244
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2025-04-14
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.